$PFE Recent News Pfizer's Rapamune doesn't meet
Post# of 5325
Posted On: 11/11/2013 4:12:53 PM
$PFE Recent News
Pfizer's Rapamune doesn't meet primary endpoint 8:51 a.m. Nov. 8, 2013 - MarketWatch.com
Is this March 2000 all over again? 3:07 p.m. Nov. 7, 2013 - Mark Hulbert
Newscast: The Dow and S&P 500 set new record highs 6:31 p.m. Oct. 29, 2013 - MarketWatch
Energy stocks gain; BP shares rally on earnings 5:12 p.m. Oct. 29, 2013 - Claudia Assis
S&P 500, Dow industrials close at record highs 4:41 p.m. Oct. 29, 2013 - Victor Reklaitis
Newscast: Wall Street heads higher and sets record 4:33 p.m. Oct. 29, 2013 - MarketWatch
U.S. stocks open higher; Pfizer rises 1% 9:36 a.m. Oct. 29, 2013 - Victor Reklaitis
Stock futures up slightly ahead of Fed meeting 9:04 a.m. Oct. 29, 2013 - Sara Sjolin
Pfizer profit falls, adjusts full-year views 7:24 a.m. Oct. 29, 2013 - MarketWatch.com
Pfizer net falls, adjusts full-year earnings range 7:18 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 revenue down 2% to $12.64 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 profit falls 19% to $2.59 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 EPS falls to $0.39; adj. EPS up to $0.58 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Cat's warning sign, a Michael Kors pop and the surf pounds Portugal 6:11 a.m. Oct. 29, 2013 - blogs.marketwatch.com
Apple, LinkedIn, Pfizer, Michael Kors: hot stocks 5:30 a.m. Oct. 29, 2013 - Ben Eisen
Apple angst, India rate hike: The next 24 hours in markets 6:17 p.m. Oct. 28, 2013 - blogs.marketwatch.com
The Next 24: Apple Angst, India Rate Hike 5:40 p.m. Oct. 28, 2013 - MarketWatch
Earnings season focus shifts to revenue, capex 9:52 a.m. Oct. 27, 2013 - Wallace Witkowski
At the NYSE, Larry Kofsky looks at the week ahead 7:01 a.m. Oct. 27, 2013 - MarketWatch
What Google and Netflix are telling us 12:37 p.m. Oct. 24, 2013 - Mark Hulbert
Verizon Makes List Of Military-Friendly Employers and 2 Other Dow Movers to Watch 1:38 p.m. Today - Wall St. Cheat Sheet
Novartis Selling Diagnostics Unit To Grifols 10:35 a.m. Today - Investors Business Daily
Orameds's Success In Type 1 Diabetes Could Solve Novo Nordisk's Problems 10:24 a.m. Today - Seeking Alpha
Shire Buys ViroPharma for $4.2 Billion 8:02 a.m. Today - WSJ.com
Pfizer And Merck Continue To Battle Declining Revenue 11:49 a.m. Nov. 10, 2013 - Seeking Alpha
10-Q: PFIZER INC 3:45 p.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
Multiple Reasons To Buy Incyte 3:25 p.m. Nov. 8, 2013 - Seeking Alpha
Make A Suave Move, Buy Novartis 2:37 p.m. Nov. 8, 2013 - Seeking Alpha
Alcoa Backs London Metal Exchange Up to a Point and 2 Other Hot Stocks to Watch 1:44 p.m. Nov. 8, 2013 - Wall St. Cheat Sheet
107-Year Old Irving Kahn Buys BP, BlackBerry, New York Community Bancorp, Sells SLM, Seaboard, ... 10:30 a.m. Nov. 8, 2013 - GuruFocus.com
AbbVie's Not as Vulnerable as the Street Believes 6:30 a.m. Nov. 8, 2013 - TheStreet.com
Merck Looks Like a Relative Bargain 6:00 a.m. Nov. 8, 2013 - TheStreet.com
Irving Kahn's High-Impact Sells in Third Quarter 5:22 p.m. Nov. 7, 2013 - GuruFocus.com
Glycomimetics IPO Is Risky But Promising 8:20 p.m. Nov. 6, 2013 - Seeking Alpha
Wal-Mart Blames Tech Glitch for Temporary Weird Prices and 2 Other Dow Movers to Watch 1:38 p.m. Nov. 6, 2013 - Wall St. Cheat Sheet
Buy Recommendation Reiterated For Pfizer Inc 9:00 a.m. Nov. 6, 2013 - TheStreet.com
Will GlaxoSmithKline Continue to Trend Higher? 8:29 a.m. Nov. 6, 2013 - Wall St. Cheat Sheet
Karyopharm Therapeutics IPO Looks Promising 7:44 a.m. Nov. 6, 2013 - Seeking Alpha
U.S. Launch of Actelion's Opsumit - Analyst Blog 4:30 p.m. Nov. 5, 2013 - Zacks.com
Ligand Pharmaceuticals On Pace For Annual Profit 4:25 p.m. Nov. 5, 2013 - Investors Business Daily
Critical Alerts For Micron Technology, Sarepta Therapeutics, Alliance Fiber Optic Products, Pfizer, and KB Home Released By InvestorsObserver 9:31 a.m. Today - PR Newswire
Pfizer Announces Top-Line Results Of Phase 3B/4 Study Of RAPAMUNE(R) (sirolimus) In Renal Transplant Recipients 8:00 a.m. Nov. 8, 2013 - BusinessWire
The Global Revolution in Biotechnology and the Impact of Regenerative Medicine 9:53 a.m. Nov. 7, 2013 - ACCESSWIRE
GlycoMimetics to Present Five Abstracts at 2013 American Society of Hematology Annual Meeting 9:11 a.m. Nov. 7, 2013 - BusinessWire
FDA Approvals, Successful Product Launches, Upcoming Earnings Schedules and Quarterly Financial Results - Research Report on Pfizer, Mettler-Toledo, Arena, Wright Medical, and Ophthotech 8:00 a.m. Nov. 7, 2013 - PR Newswire
2013 mHealth Summit Launches First Pharma and Life Sciences Roundtable 2:31 p.m. Nov. 6, 2013 - PR Newswire
Former U.S. President Jimmy Carter And Pfizer Celebrate 15-Year Effort To Help End Blinding Trachoma As A Public Health Concern 12:32 p.m. Nov. 5, 2013 - BusinessWire
Pfizer Receives FDA Approval for a Prior Approval Supplement for EMBEDA(R) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII 5:14 p.m. Nov. 4, 2013 - BusinessWire
Therapeutic Area Partnerships Feature Pharma Leaders Who Unveil How to Pick Drug Targets, Partners, and Deal Models Most Likely to Succeed 9:00 a.m. Nov. 4, 2013 - Marketwire
Dividend, Quarterly Report, Recognition, Study Results, and New Drug Application - Research Report on Pfizer, Lilly, Regeneron, Vertex, and GSK 9:00 a.m. Nov. 1, 2013 - PR Newswire
Critical Stock Analysis: Pfizer, Barrick Gold Corporation, Micron Technology, Wells Fargo, Zynga 8:50 a.m. Nov. 1, 2013 - PR Newswire
Pain Therapeutics Reports Q3 2013 Financial Results 8:00 a.m. Oct. 31, 2013 - GlobeNewswire
NLY, BAC, DDD and PFE added to NYSE Active Stock Watch List at GSR 9:28 a.m. Oct. 29, 2013 - ACCESSWIRE
Cannabis Biotech in Talks With Research Chemist to Explore Transmucosal Delivery 8:30 a.m. Oct. 29, 2013 - BusinessWire
Pfizer Reports Third-Quarter 2013 Results 7:00 a.m. Oct. 29, 2013 - BusinessWire
Positive Clinical Trial Results, Patient Enrollment, and Collaborations - Research Report on Pfizer, Medivation, AbbVie, Cigna, and AstraZeneca 9:00 a.m. Oct. 28, 2013 - PR Newswire
Nodality, Inc. Announces Presentations at 2013 American College of Rheumatology Annual Meeting 7:30 a.m. Oct. 28, 2013 - BusinessWire
Howie Mandel Challenges People To Learn The Fibs And Facts About Atrial Fibrillation And Its Associated Increased Stroke Risk 6:00 a.m. Oct. 28, 2013 - BusinessWire
Pre-Market Analysis: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. 10:12 a.m. Oct. 25, 2013 - PR Newswire
Pfizer Declares 24-Cent Fourth-Quarter 2013 Dividend 4:00 p.m. Oct. 24, 2013 - BusinessWire
Pfizer's Rapamune doesn't meet primary endpoint 8:51 a.m. Nov. 8, 2013 - MarketWatch.com
Is this March 2000 all over again? 3:07 p.m. Nov. 7, 2013 - Mark Hulbert
Newscast: The Dow and S&P 500 set new record highs 6:31 p.m. Oct. 29, 2013 - MarketWatch
Energy stocks gain; BP shares rally on earnings 5:12 p.m. Oct. 29, 2013 - Claudia Assis
S&P 500, Dow industrials close at record highs 4:41 p.m. Oct. 29, 2013 - Victor Reklaitis
Newscast: Wall Street heads higher and sets record 4:33 p.m. Oct. 29, 2013 - MarketWatch
U.S. stocks open higher; Pfizer rises 1% 9:36 a.m. Oct. 29, 2013 - Victor Reklaitis
Stock futures up slightly ahead of Fed meeting 9:04 a.m. Oct. 29, 2013 - Sara Sjolin
Pfizer profit falls, adjusts full-year views 7:24 a.m. Oct. 29, 2013 - MarketWatch.com
Pfizer net falls, adjusts full-year earnings range 7:18 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 revenue down 2% to $12.64 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 profit falls 19% to $2.59 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 EPS falls to $0.39; adj. EPS up to $0.58 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Cat's warning sign, a Michael Kors pop and the surf pounds Portugal 6:11 a.m. Oct. 29, 2013 - blogs.marketwatch.com
Apple, LinkedIn, Pfizer, Michael Kors: hot stocks 5:30 a.m. Oct. 29, 2013 - Ben Eisen
Apple angst, India rate hike: The next 24 hours in markets 6:17 p.m. Oct. 28, 2013 - blogs.marketwatch.com
The Next 24: Apple Angst, India Rate Hike 5:40 p.m. Oct. 28, 2013 - MarketWatch
Earnings season focus shifts to revenue, capex 9:52 a.m. Oct. 27, 2013 - Wallace Witkowski
At the NYSE, Larry Kofsky looks at the week ahead 7:01 a.m. Oct. 27, 2013 - MarketWatch
What Google and Netflix are telling us 12:37 p.m. Oct. 24, 2013 - Mark Hulbert
Verizon Makes List Of Military-Friendly Employers and 2 Other Dow Movers to Watch 1:38 p.m. Today - Wall St. Cheat Sheet
Novartis Selling Diagnostics Unit To Grifols 10:35 a.m. Today - Investors Business Daily
Orameds's Success In Type 1 Diabetes Could Solve Novo Nordisk's Problems 10:24 a.m. Today - Seeking Alpha
Shire Buys ViroPharma for $4.2 Billion 8:02 a.m. Today - WSJ.com
Pfizer And Merck Continue To Battle Declining Revenue 11:49 a.m. Nov. 10, 2013 - Seeking Alpha
10-Q: PFIZER INC 3:45 p.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
Multiple Reasons To Buy Incyte 3:25 p.m. Nov. 8, 2013 - Seeking Alpha
Make A Suave Move, Buy Novartis 2:37 p.m. Nov. 8, 2013 - Seeking Alpha
Alcoa Backs London Metal Exchange Up to a Point and 2 Other Hot Stocks to Watch 1:44 p.m. Nov. 8, 2013 - Wall St. Cheat Sheet
107-Year Old Irving Kahn Buys BP, BlackBerry, New York Community Bancorp, Sells SLM, Seaboard, ... 10:30 a.m. Nov. 8, 2013 - GuruFocus.com
AbbVie's Not as Vulnerable as the Street Believes 6:30 a.m. Nov. 8, 2013 - TheStreet.com
Merck Looks Like a Relative Bargain 6:00 a.m. Nov. 8, 2013 - TheStreet.com
Irving Kahn's High-Impact Sells in Third Quarter 5:22 p.m. Nov. 7, 2013 - GuruFocus.com
Glycomimetics IPO Is Risky But Promising 8:20 p.m. Nov. 6, 2013 - Seeking Alpha
Wal-Mart Blames Tech Glitch for Temporary Weird Prices and 2 Other Dow Movers to Watch 1:38 p.m. Nov. 6, 2013 - Wall St. Cheat Sheet
Buy Recommendation Reiterated For Pfizer Inc 9:00 a.m. Nov. 6, 2013 - TheStreet.com
Will GlaxoSmithKline Continue to Trend Higher? 8:29 a.m. Nov. 6, 2013 - Wall St. Cheat Sheet
Karyopharm Therapeutics IPO Looks Promising 7:44 a.m. Nov. 6, 2013 - Seeking Alpha
U.S. Launch of Actelion's Opsumit - Analyst Blog 4:30 p.m. Nov. 5, 2013 - Zacks.com
Ligand Pharmaceuticals On Pace For Annual Profit 4:25 p.m. Nov. 5, 2013 - Investors Business Daily
Critical Alerts For Micron Technology, Sarepta Therapeutics, Alliance Fiber Optic Products, Pfizer, and KB Home Released By InvestorsObserver 9:31 a.m. Today - PR Newswire
Pfizer Announces Top-Line Results Of Phase 3B/4 Study Of RAPAMUNE(R) (sirolimus) In Renal Transplant Recipients 8:00 a.m. Nov. 8, 2013 - BusinessWire
The Global Revolution in Biotechnology and the Impact of Regenerative Medicine 9:53 a.m. Nov. 7, 2013 - ACCESSWIRE
GlycoMimetics to Present Five Abstracts at 2013 American Society of Hematology Annual Meeting 9:11 a.m. Nov. 7, 2013 - BusinessWire
FDA Approvals, Successful Product Launches, Upcoming Earnings Schedules and Quarterly Financial Results - Research Report on Pfizer, Mettler-Toledo, Arena, Wright Medical, and Ophthotech 8:00 a.m. Nov. 7, 2013 - PR Newswire
2013 mHealth Summit Launches First Pharma and Life Sciences Roundtable 2:31 p.m. Nov. 6, 2013 - PR Newswire
Former U.S. President Jimmy Carter And Pfizer Celebrate 15-Year Effort To Help End Blinding Trachoma As A Public Health Concern 12:32 p.m. Nov. 5, 2013 - BusinessWire
Pfizer Receives FDA Approval for a Prior Approval Supplement for EMBEDA(R) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII 5:14 p.m. Nov. 4, 2013 - BusinessWire
Therapeutic Area Partnerships Feature Pharma Leaders Who Unveil How to Pick Drug Targets, Partners, and Deal Models Most Likely to Succeed 9:00 a.m. Nov. 4, 2013 - Marketwire
Dividend, Quarterly Report, Recognition, Study Results, and New Drug Application - Research Report on Pfizer, Lilly, Regeneron, Vertex, and GSK 9:00 a.m. Nov. 1, 2013 - PR Newswire
Critical Stock Analysis: Pfizer, Barrick Gold Corporation, Micron Technology, Wells Fargo, Zynga 8:50 a.m. Nov. 1, 2013 - PR Newswire
Pain Therapeutics Reports Q3 2013 Financial Results 8:00 a.m. Oct. 31, 2013 - GlobeNewswire
NLY, BAC, DDD and PFE added to NYSE Active Stock Watch List at GSR 9:28 a.m. Oct. 29, 2013 - ACCESSWIRE
Cannabis Biotech in Talks With Research Chemist to Explore Transmucosal Delivery 8:30 a.m. Oct. 29, 2013 - BusinessWire
Pfizer Reports Third-Quarter 2013 Results 7:00 a.m. Oct. 29, 2013 - BusinessWire
Positive Clinical Trial Results, Patient Enrollment, and Collaborations - Research Report on Pfizer, Medivation, AbbVie, Cigna, and AstraZeneca 9:00 a.m. Oct. 28, 2013 - PR Newswire
Nodality, Inc. Announces Presentations at 2013 American College of Rheumatology Annual Meeting 7:30 a.m. Oct. 28, 2013 - BusinessWire
Howie Mandel Challenges People To Learn The Fibs And Facts About Atrial Fibrillation And Its Associated Increased Stroke Risk 6:00 a.m. Oct. 28, 2013 - BusinessWire
Pre-Market Analysis: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. 10:12 a.m. Oct. 25, 2013 - PR Newswire
Pfizer Declares 24-Cent Fourth-Quarter 2013 Dividend 4:00 p.m. Oct. 24, 2013 - BusinessWire
(0)
(0)Scroll down for more posts ▼